Asianet Newsable on MSN

Novartis Stock Rises Premarket After FDA Approves First Gene Therapy For Teens And Adults With Muscle-Weakening Disorder

FDA cleared Itvisma as the first gene-replacement therapy available to people 2 and older with the rare muscle-weakening ...
Health eCareers on MSN

The Most In-Demand Healthcare Jobs in 2025 — and How to Land Them

Healthcare hiring is on the rise, and allied health roles are some of the most in-demand healthcare jobs. Specifically, ...
MyHorryNews

Novartis receives FDA approval for Itvisma®, the only gene replacement therapy for children two years and older, teens, and adults with spinal muscular atrophy (SMA)

Itvisma (onasemnogene abeparvovec-brve) demonstrated improved motor function and stabilization in patients regardless of SMA treatment history in Phase III studiesOne-time dose of Itvisma replaces ...

Novartis receives FDA approval for Itvisma(R), the only gene replacement therapy for children two years and older, teens, and adults with spinal muscular atrophy (SMA)

ITVISMA is a prescription gene therapy used to treat adults and children 2 years of age and older with spinal muscular atrophy (SMA). ITVISMA is given as a one-time intrathecal injection. What is the ...
The Valdosta Daily Times

SRTC Respiratory Care students honored during pinning ceremony

On Nov. 13, thirteen Southern Regional Technical College Respiratory Care graduates were honored during a pinning ceremony in Thomasville.
SDG News Group

Ohio House approves bill establishing advanced practice respiratory therapist designation

State Representatives Marilyn John (R-Richland County) and Tom Young (R-Washington Twp.) today announced that legislation ...

Windtree Therapeutics Announces It May Receive License Agreement Payments from Its Licensee for Renewed Acute Pulmonary Development by the Licensee

The Company has a global license agreement for the acute pulmonary that could pay up to $78.9 million in development, regulatory and commercial ...

NanoViricides to Present at the Pharma Partnering Summit 2025 in Boston Today, November 14th - NV-387 is Effective Against H3N2

NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader developing revolutionary broad-spectrum ...
Richland Source

Marilyn John-sponsored bill on respiratory therapy passed by House

A bill creating an advanced licensure pathway for respiratory therapists passed through the Ohio House of Representatives, ...
Hays Post

Rodrigo Perez Gonzalez named Respiratory Therapist of the Year

(Left to right) Brian Pfannenstiel, Director of Critical Care; Rodrigo Perez Gonzalez, RT of the Year; Joben Rieth, VP of Patient Care Services & CNO. Courtesy [hptp HaysMed is proud to announce that ...